Reviews
The most revolutionary treatment for the clinical application of the 867 kill-killing treatment, the revolution of the elderly, and the post-medic atherosclerosis and aging. A study on the diet of the 867 kill therapy was published in this one volume. In the "The Clinical Application of ED7 Killification" treatment, the author says that the clinical application of the 867 kill therapy will be of great help to doctors who want to solve the treatment of atherosclerosis and aging. Is the patient's
The National Institutes of Health and Hearts has published the study in a very positive way. Author Goldmer M. Dr. Cranton is the chief authority in the study of kill, which has taken over the president of the World Academy of Sciences, representing integration functional medicine. On March 27, 2013, the National Institutes of Health and Hearts successfully completed their clinical trial at the GoogleCTR. Heart disease has declined by 18 percent, stroke has decreased 23 percent, and diabetes
Elmer Cranton: Clinical Application of EDTA Chelation Therapy
Killion therapy through IVF is a very effective treatment for atherosclerosis and cardiovascular disease. Security and effectiveness have been demonstrated through clinical trials, and so far, with the support of the board, they are effective in millions of patients. In this book, such as the textbook on the 867-acquired kill rate, Dr. Elmer Cranton, a leading killer therapy expert, systematically reviews and sorts out the research of global experts. If you have introduced a whole series of cases of treatment, along with a comprehensive description of the process, the "Dedcast Kill" will serve as a guide to the clinical application of treatment and to the patient at the scene, consistent scientific basis, multiple clinical trials, detailed protocols for injections, guidelines for safety, and so on.
Korean title: EDTA 킬레이션 치료의 임상적용
Korean author: 엘머 크랜턴
Korean publisher: 김영사
ISBN-13: 9788934911005
Reviews
The most revolutionary treatment for the clinical application of the 867 kill-killing treatment, the revolution of the elderly, and the post-medic atherosclerosis and aging. A study on the diet of the 867 kill therapy was published in this one volume. In the "The Clinical Application of ED7 Killification" treatment, the author says that the clinical application of the 867 kill therapy will be of great help to doctors who want to solve the treatment of atherosclerosis and aging. Is the patient's
The National Institutes of Health and Hearts has published the study in a very positive way. Author Goldmer M. Dr. Cranton is the chief authority in the study of kill, which has taken over the president of the World Academy of Sciences, representing integration functional medicine. On March 27, 2013, the National Institutes of Health and Hearts successfully completed their clinical trial at the GoogleCTR. Heart disease has declined by 18 percent, stroke has decreased 23 percent, and diabetes
